Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry

Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry

Abstract Background Studies have shown that the concomitant use of a vitamin K antagonist (VKA) and an antiplatelet (APL) drug increased the bleeding risk and was less effective at preventing ischemic events. This study aimed to investigate the control status of international normalized ratio (INR)...

Full description

Bibliographic Details
Main Authors: Hee‐Soon Park, Young‐Hoon Kim, June Soo Kim, Yong‐Seog Oh, Dong‐Gu Shin, Hui‐Nam Pak, Gyo‐Seung Hwang, Kee‐Joon Choi, Seil Oh, Jin‐Bae Kim, Man‐Young Lee, Hyung‐Wook Park, Dae‐Kyeong Kim, Eun‐Sun Jin, Jae‐Seok Park, Il‐Young Oh, Dae‐Hee Shin, Hyoung‐Seob Park, Jun Hyung Kim, Nam‐Ho Kim, Min‐Soo Ahn, Bo‐Jeong Seo, Young‐Joo Kim, Seongsik Kang, Juneyoung Lee
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Journal of Arrhythmia
Subjects:
anticoagulants
atrial fibrillation
International normalized ratio
platelet aggregation inhibitors
Warfarin
Online Access:https://doi.org/10.1002/joa3.12183

Internet

https://doi.org/10.1002/joa3.12183

Similar Items